Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Vertex Hepatitis C Drug Study Shows Good Results

May 24, 2006

On Monday, Vertex Pharmaceuticals reported good results for its hepatitis C drug candidate in all of the subjects tested in a mid-stage clinical trial. Among the 12 subjects taking the firm's drug VX-950 in combination with ribavirin and pegylated interferon alfa-2a, all had their virus reduced to undetectable levels after 28 days of treatment. After 12 more weeks, 11 patients continued to have no detectable HCV.

Back to other news for May 24, 2006

Adapted from:
Associated Press
05.22.06


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement